FR2817875B1 - Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation - Google Patents

Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation

Info

Publication number
FR2817875B1
FR2817875B1 FR0015927A FR0015927A FR2817875B1 FR 2817875 B1 FR2817875 B1 FR 2817875B1 FR 0015927 A FR0015927 A FR 0015927A FR 0015927 A FR0015927 A FR 0015927A FR 2817875 B1 FR2817875 B1 FR 2817875B1
Authority
FR
France
Prior art keywords
antibodies
fragments
preparation
monoclonal antibody
human monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0015927A
Other languages
English (en)
Other versions
FR2817875A1 (fr
Inventor
Jacques Noury
Herve Bazin
Dominique Latinne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technopharm SARL
Original Assignee
Technopharm SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technopharm SARL filed Critical Technopharm SARL
Priority to FR0015927A priority Critical patent/FR2817875B1/fr
Priority to AU2002217212A priority patent/AU2002217212A1/en
Priority to PCT/FR2001/003881 priority patent/WO2002046233A1/fr
Publication of FR2817875A1 publication Critical patent/FR2817875A1/fr
Application granted granted Critical
Publication of FR2817875B1 publication Critical patent/FR2817875B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
FR0015927A 2000-12-07 2000-12-07 Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation Expired - Fee Related FR2817875B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0015927A FR2817875B1 (fr) 2000-12-07 2000-12-07 Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation
AU2002217212A AU2002217212A1 (en) 2000-12-07 2001-12-07 Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof
PCT/FR2001/003881 WO2002046233A1 (fr) 2000-12-07 2001-12-07 Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0015927A FR2817875B1 (fr) 2000-12-07 2000-12-07 Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation

Publications (2)

Publication Number Publication Date
FR2817875A1 FR2817875A1 (fr) 2002-06-14
FR2817875B1 true FR2817875B1 (fr) 2005-03-18

Family

ID=8857377

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0015927A Expired - Fee Related FR2817875B1 (fr) 2000-12-07 2000-12-07 Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation

Country Status (3)

Country Link
AU (1) AU2002217212A1 (fr)
FR (1) FR2817875B1 (fr)
WO (1) WO2002046233A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9290786B2 (en) 2003-02-26 2016-03-22 Institute For Research In Biomedicine Monoclonal antibody production by EBV transformation of B cells

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
ES2368733T3 (es) 2002-07-18 2011-11-21 Merus B.V. Producción recombinante de mezclas de anticuerpos.
CA2527694C (fr) 2003-05-30 2015-07-14 Hendricus Renerus Jacobus Mattheus Hoogenboom Banque de fab pour la preparation de fab anti-vegf et antirabique
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
EP1737971B1 (fr) 2004-01-20 2017-08-16 Merus N.V. Mélanges de proteines de liason
AU2006325236B2 (en) 2005-12-16 2011-11-10 Ribovax Biotechnologies Sa Methods for obtaining immortalized antibody secreting cells
US8568719B2 (en) 2009-08-13 2013-10-29 Crucell Holland B.V. Antibodies against human respiratory syncytial virus (RSV) and methods of use
US9260517B2 (en) 2009-11-17 2016-02-16 Musc Foundation For Research Development Human monoclonal antibodies to human nucleolin
EA027835B1 (ru) 2010-07-09 2017-09-29 Круселл Холланд Б.В. Антитела против респираторно-синцитиального вируса (рсв) и способы их применения
MX360109B (es) 2012-04-20 2018-10-23 Merus Nv Metodos y medios para la produccion de moleculas de tipo ig.
US11578132B2 (en) 2017-01-16 2023-02-14 Kaneka Corporation Method for producing B cell population and method for producing monoclonal antibody using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043718B1 (fr) * 1980-07-07 1984-11-28 National Research Development Corporation Lignées de cellules
US5811248A (en) * 1986-03-31 1998-09-22 Charter Ventures Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9290786B2 (en) 2003-02-26 2016-03-22 Institute For Research In Biomedicine Monoclonal antibody production by EBV transformation of B cells

Also Published As

Publication number Publication date
FR2817875A1 (fr) 2002-06-14
WO2002046233A1 (fr) 2002-06-13
AU2002217212A1 (en) 2002-06-18

Similar Documents

Publication Publication Date Title
PT941121E (pt) Preparados farmaceuticos liofilizados, estaveis, de anticorpos monoclonais ou policlonais
FR2817875B1 (fr) Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation
EE05309B1 (et) β-Amloidpeptiidi „ratundvad humaniseeritud antikehad, meetod nende valmistamiseks, nende kasutamine ja farmatseutiline kompositsioon
HUP0200537A2 (en) Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
BR9609035A (pt) Anticorpos monoclonais de macaco específicos para formas primatizadas B7.1 e/ou B&.2 humanas composições farmacéuticas
WO2002020569A3 (fr) Genes mammaliens, reactifs et methodes associes
AU1462300A (en) Human pan-hcv human monoclonal antibodies
EP1908837A3 (fr) Protéines humaines réceptrices, réactifs associés et procédés
HUP9702359A3 (en) Monoclonal antibody, method of preparing a monoclonal antibody, and pharmaceutical composition and a diagnostic reagent comprising the monoclonal antibody
NO986088D0 (no) Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisi
WO1999046379A3 (fr) Proteines receptrices humaines; reactifs et procedes associes
EA200400134A1 (ru) Терапевтический агент
FR2817869B1 (fr) Anticorps monoclonal humain dirige contre le virus influenza ou un fragment de celui-ci
AU7160691A (en) Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes
AU1538392A (en) Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations
FR2804027B1 (fr) Utilisation d'anticorps monoclonaux anti-ferritines dans le traitement de certains cancers
IL101201A0 (en) Methods for selecting antibody reagents,anti-idiotype antibodies and aids vaccine formulations
AU7068587A (en) Monoclonal antibody immunoblot assay for antigens
AU2001255537A1 (en) Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
AU5809290A (en) Monoclonal antibodies involved in alzheimer's disease, hybridomas secreting these monoclonal antibodies, antigen recognized by these antibodies, and their application
FR2757864B1 (fr) Anticorps reconnaissant specifiquement une proteine nitrosylee, leur procede de preparation, leur utilisation therapeutique et diagnostique
FR2775691B1 (fr) Anticorps monoclonaux specifiques de la proteine esm-1, et utilisation de ces anticorps pour la detection de la proteine esm-1
AU7128098A (en) Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies
FR2771552B1 (fr) Transducteur d'emission-reception d'energie radioelectrique hyperfrequence
AU2169797A (en) Improved production of antibodies through the use of antigen antibody complexes

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060831